Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Astec Lifesciences Limited ( (IN:ASTEC) ) has provided an announcement.
Astec LifeSciences Limited has announced the re-appointment of Mr. Nandkumar Dhekne as a Non-Executive & Independent Director for a second term of five years, starting from December 18, 2025, to December 17, 2030, pending shareholder approval. This decision, approved by the Board of Directors based on the Nomination and Remuneration Committee’s recommendation, underscores the company’s commitment to maintaining experienced leadership. Mr. Dhekne brings extensive experience in operations management and leadership roles across Asia Pacific, which is likely to positively influence Astec’s strategic direction and stakeholder confidence.
More about Astec Lifesciences Limited
Average Trading Volume: 2,086
Technical Sentiment Signal: Sell
Current Market Cap: 17.93B INR
For an in-depth examination of ASTEC stock, go to TipRanks’ Overview page.

